Effect of maximal reduction of angiotensin in renal fibrosis: bad news-good news from a pediatric mouse.
Border
W A
WA
Fibrosis Research Laboratory, Salt Lake City, UT 84108, USA. wayne.border@hsc.utah.edu
Noble
N A
NA
D000804:Angiotensin II / Q000037:antagonists & inhibitors / Q000502:physiology; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000808:Angiotensinogen / Q000235:genetics; D000818:Animals; D004195:Disease Models, Animal; D005355:Fibrosis; D007674:Kidney Diseases / Q000188:drug therapy*; D051379:Mice; D017395:Plasminogen Activator Inhibitor 1 / Q000378:metabolism*; D012084:Renin-Angiotensin System / Q000502:physiology*; D016212:Transforming Growth Factor beta / Q000378:metabolism*; D014517:Ureteral Obstruction / Q000150:complications
D000806:Angiotensin-Converting Enzyme Inhibitors; D017395:Plasminogen Activator Inhibitor 1; D016212:Transforming Growth Factor beta; D000808:Angiotensinogen; D000804:Angiotensin II